Nanoveu Secures AU$ 7.5 million Funding to Accelerate ECS-DoT Commercialisation
Nanoveu Limited (ASX: NVU) has received firm commitments to raise AU$ 7.5 million through a strategic placement, strengthening its balance sheet to accelerate the commercialisation of its ECS-DoT semiconductor technology. The funding will support the progression of the next-generation sixteen-nanometre system-on-a-chip, live drone validation trials in the United States, and the broader rollout of EMASS’s commercial platform. The Company has delivered final GDS for the sixteen-nanometre ECS-DoT into the TSMC and IMEC workflow and has progressed from architecture to final design in approximately six months, materially faster than typical advanced-node development timelines. Live drone testing is now underway following extensive simulation campaigns that demonstrated flight endurance improvements of more than fifty percent, positioning Nanoveu to advance toward initial design-ins and commercial outcomes.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Nanoveu Secures AU$ 7.5 million Funding to Accelerate ECS-DoT Commercialisation
Nanoveu Limited (ASX: NVU) has received firm commitments to raise AU$ 7.5 million through a strategic placement, strengthening its balance sheet to accelerate the commercialisation of its ECS-DoT semiconductor technology. The funding will support the progression of the next-generation sixteen-nanometre system-on-a-chip, live drone validation trials in the United States, and the broader rollout of EMASS’s commercial platform. The Company has delivered final GDS for the sixteen-nanometre ECS-DoT into the TSMC and IMEC workflow and has progressed from architecture to final design in approximately six months, materially faster than typical advanced-node development timelines. Live drone testing is now underway following extensive simulation campaigns that demonstrated flight endurance improvements of more than fifty percent, positioning Nanoveu to advance toward initial design-ins and commercial outcomes.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au